WASHINGTON, D.C. May 29, 2014 Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) commending the Food and Drug Administration (FDA) for finalizing its order to reclassify indoor tanning devices from a class I to a class II medical device, imposing greater control over their manufacture and distribution. The FDA took a critical step today to protect Americans from the dangers of indoor tanning devices, the use of which can increase an individual 's risk of melanoma by 59 percent. This long-awaited order means the FDA can finally require manufacturers to display labels that warn against the use of tanning devices by those under 18, and hold manufacturers to stricter safety and performance standards. Because the tanning industry continues to disregard the harmful effects of its products, it is imperative that we protect public health and educate youth about the carcinogenic hazards of indoor tanning. ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visitæhttps://www.fightcancer.org/. FOR MORE INFORMATION, CONTACT: Lauren Walens or Steven Weiss American Cancer Society Cancer Action Network Phone: (202) 661-5763 or (202) 661-5711 Email: [email protected] or [email protected] #FDA #tanning #skincancer #melanoma #tanningbed #UV #ACSCAN